|SATURDAY, FEBRUARY 6
Session 1: Tumor Biomarkers and Diagnostics
Co-Chairpersons: Motoharu Seiki, University of Tokyo, Tokyo, Japan, and Gordon B. Mills, UT M. D. Anderson Cancer Center, Houston, TX, USA
8:00 a.m.-9:30 a.m.
Delivering on the promise of personalized molecular medicine
Gordon B. Mills
Identification of biomarkers and therapy targets by proteomics
Tesshi Yamada, National Cancer Center Research Institute, Tokyo, Japan
Targeting ErbB3 in ErbB2-expressing breast cancers
Rebecca S. Cook, Vanderbilt University, Nashville, TN
Session 2: Pharmacogenomics
Co-Chairpersons: Yusuke Nakamura, University of Tokyo, Tokyo, Japan, and Daniel A. Haber, Massachusetts General Hospital, Charlestown, MA, USA
10:00 a.m.-11:30 a.m.
Pharmacogenomics-based individualization of anticancer therapeutics
Taisei Mushiroda, RIKEN, Tokyo, Japan
Molecular characterization of circulating tumor cells
Daniel A. Haber
Pharmacogenetics of irinotecan in Japanese patients with cancer
Hironobu Minami, Kobe University Graduate School of Medicine, Kobe, Japan
Session 3: New Approaches to Cancer Immunotherapy
Co-Chairpersons: Louis M. Weiner, Lombardi Comprehensive Cancer Center at Georgetown University, Washington, DC, USA, and Masanori Hatakeyama, Hokkaido University, Sapporo, Japan
11:30 a.m.-1:00 p.m.
Monoclonal antibody immunotherapy
Louis M. Weiner
Improvement of immunotherapy by restoration of immunocompetence through targeting signaling molecules in cancer and immune cells
Yutaka Kawakami, Keio University, Tokyo, Japan
Immune correlates of clinical outcomes in dendritic cells vaccination
A. Karolina Palucka, Baylor University Medical Center, Dallas, TX, USA
Poster Session A
6:30 p.m.-8:00 p.m.
Session 4: Drug Delivery Systems for Cancer Therapy
Co-Chairpersons: Kohei Miyazono, University of Tokyo, Tokyo, Japan, and Sara A. Courtneidge, Burnham Institute for Medical Research, La Jolla, CA, USA
8:00 p.m.-9:30 p.m.
Individualized therapeutics through the rational design of multistage nanovectors
Mauro Ferrari, UT Health Science Center, Houston, TX, USA
Polymeric micellar drugs and gene vectors for cancer treatment
Kazunori Kataoka, University of Tokyo School of Engineering, Tokyo, Japan
Targeting tumors using viral nanoparticles (VNPs)
Marianne Manchester, The Scripps Research Institute, La Jolla, CA, USA